Nederlandse Vereniging voor Medische Oncologie

What Nederlandse Vereniging voor Medische Oncologie does

The Nederlandse Vereniging voor Medische Oncologie (NVMO) is a Dutch non-profit professional medical association founded on 20 October 1997 and headquartered at Domus Medica in Utrecht, the Netherlands. The organization serves Dutch internist-oncologists (medical oncologists) and physicians in training to become internist-oncologists, acting as the sole dedicated professional society for medical oncology in the Netherlands — filling a gap left by the broader Nederlandse Internisten Vereeniging (NIV) and earlier oncology bodies. NVMO operates a website-based member platform (nvmo.org) and publishes the journal Medische Oncologie (10 issues per year) at medischeoncologie.nl. Its technology stack consists of a member portal with login-gated content, an integrated e-learning platform distributed via a partnership with MEDtalks (medtalks.nl), webcast and webinar infrastructure for congress recordings (Oncologiedagen, Post-ASCO, Post-ESMO, Therapie op Maat, jNVMO webinars), and a newsletter distribution system. NVMO's commissions — BOM (drug advice), DAP, OOM (off-label oncology drug indications), CieDD (efficiency and sustainability), and cieKNT (clinically necessary molecular targets, established April 2024) — produce official clinical guidance and drug-access protocols referenced across Dutch oncology practice.

NVMO is funded primarily through recurring annual membership dues: EUR 302.50 per year for fully qualified internist-oncologists, EUR 60.50 for those in training, and EUR 60.50 for retired members (2024 pricing). The journal is provided free of charge to non-member medical specialists who register on the journal website. E-learning content and webcasts are free to members, with pharmaceutical sponsorship underwriting individual programs while NVMO retains editorial independence. NVMO's customer base is concentrated on Dutch internist-oncologists, with a secondary interface to Dutch healthcare insurers (Zorgverzekeraars Nederland) for reimbursement code determinations. Strategic partnerships include MEDtalks (e-learning distribution), Zorgverzekeraars Nederland (drug reimbursement liaison), NVCO and NVRO (joint interdisciplinary congress Therapie op Maat), BPM Medica (editorial execution), and NIV (e-learning accreditation). The organization employs approximately 22 people.

Name

Nederlandse Vereniging voor Medische Oncologie

Legal name

Nederlandse Vereniging voor Medische Oncologie

Website

https://nvmo.org

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

11–50 employees

Short description

NVMO is the Dutch non-profit professional society for medical oncologists, founded in 1997 and headquartered in Utrecht. It serves Dutch internist-oncologists through membership dues, the journal Medische Oncologie, MEDtalks-distributed e-learning, and official drug-advice commissions interfacing with national healthcare insurers.

Ownership category

akta.pro rank

Product category

Professional Medical Association Services

akta.pro industry

PRIMARYHLAKAFAB

Medical Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

Keywords

• Medical oncology
• Professional association
• Clinical guidelines
• Continuing medical education
• Oncology research

Headquarters

HQ city

Utrecht

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Dues: NVMO generates revenue primarily through annual membership dues from internist-oncologists. Membership includes a subscription to the journal Medische Oncologie, access to the NVMO website with all member-exclusive content, and free participation in various NVMO trainings and symposia.

Pricing tiers

Distribution channels4 records

Marketing channels6 records

Core offering

The NVMO is a Dutch professional medical association that serves internist-oncologists through its peer-reviewed journal Medische Oncologie, accredited e-learning programs, committee-published clinical guidance and drug access advice (BOM, OOM, DAP, CieDD, CieKNT), annual congresses (Oncologiedagen, Post-ASCO, Post-ESMO), and a member-only website. It also acts as the formal liaison with Zorgverzekeraars Nederland for add-on oncology drug declaration codes and represents internist-oncologists in national oncology policy.

Product overview

The Nederlandse Vereniging voor Medische Oncologie (NVMO) is a professional medical association for internist-oncologists in the Netherlands. The organization functions as a professional society and community platform rather than a technology product company. Its primary offerings include: the journal Medische Oncologie (published 10 times per year), e-learning modules covering various oncology topics such as breast cancer, colorectal cancer, prostate cancer, melanoma, bladder cancer, kidney cell carcinoma, ovarian cancer, and oncological pharmacology, webcasts and webinars of congresses including the Oncologiedagen and Therapie op Maat, and committee advice publications (BOM, OOM, DAP, KNT) providing guidance on oncology treatments and drug access protocols.

Differentiator

Problem solved

Functional benefit

Products and services

• Tijdschrift Medische Oncologie (Journal) Official NVMO journal published 10 times per year, covering scientific articles, interviews, and clinical guidance for medical oncologists. Mailed to NVMO members and made available to non-member medical specialists who register on the journal website.
• NVMO E-learning Program (via MEDtalks) Accredited online continuing education programs covering oncology topics including breast cancer, colorectal cancer, prostate cancer, melanoma, and oncological pharmacology, delivered in cooperation with MEDtalks and freely available to NVMO members and registered medical specialists.
• Oncologiedagen (Annual Congress) Premier annual oncology congress for Netherlands and Flanders, held at Congrescentrum Papendal, gathering Dutch-speaking oncologists for clinical updates and networking.
• Therapie op Maat (Biennial Interdisciplinary Congress) Biennial interdisciplinary congress jointly organized by NVMO, NVCO (surgical oncology), and NVRO (radiotherapy) for cross-disciplinary treatment discussions across surgical, medical, and radiation oncology.
• NVMO Committee Advice (BOM, OOM, DAP, CieDD, CieKNT) Official committee advice published by NVMO commissions (BOM, OOM, DAP, CieDD, CieKNT) covering oncology drug recommendations, drug access protocols for reimbursement, molecular diagnostics (KNT lists), and efficiency/sustainability guidance. Used across Dutch oncology practice and referenced by Zorgverzekeraars Nederland for add-on drug declaration codes.
• NVMO Membership Annual membership offered by the NVMO to internist-oncologists in the Netherlands. Tiered pricing: fully qualified internist-oncoloog EUR 302.50 per year, internist-oncoloog in opleiding EUR 60.50 per year, gepensioneerd internist-oncoloog EUR 60.50 per year (2024). Includes journal subscription, website access with member-exclusive content, and free participation in NVMO trainings and symposia.
• NVMO Webcasts and Webinars (Post-ASCO, Post-ESMO recordings) On-demand webcasts of NVMO congresses (Oncologiedagen, Post-ASCO, Post-ESMO, Therapie op Maat) and jNVMO webinars, accessible to members through the NVMO website.
• jNVMO Educational Events (Landelijke Onderwijsdag, Indian Summer School, WaddenWorkshopOncologie) Educational events organized by the jNVMO (young NVMO) subgroup for medical oncologists in training, including the Landelijke Onderwijsdag, Indian Summer School, and WaddenWorkshopOncologie.

Quantifiable outcome

• NVMO commissions (BOM, OOM, DAP, CieDD, CieKNT) publish regular drug and treatment advice that is referenced across Dutch oncology practice.
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Zorgverzekeraars Nederland (ZN)coreStrategic or Co-development PartnerNVMO has a formal liaison function with Zorgverzekeraars Nederland (ZN) regarding declaration codes for add-on oncology medications. The NVMO-commissie OOM (Off-label indicatiestelling Oncologische Middelen) evaluates requests from the ZN-commissie Beoordeling Add-on Geneesmiddelen (CieBAG) as well as individual or collaborative NVMO or NVALT members for add-on declaration codes for specific off-label indications. This partnership is central to NVMO's role in the Dutch healthcare reimbursement system.
• MEDtalkscoreGTM or Marketing PartnerNVMO has a cooperation agreement with MEDtalks for the production and distribution of e-learning programs. E-learning content (on topics such as mammacarcinoom, colorectaal carcinoom, prostaatcarcinoom, melanoom, etc.) is hosted on the MEDtalks platform and made available free of charge to NVMO members and registered medical specialists. While pharmaceutical companies provide financial sponsorship for individual programs, editorial independence is maintained.
• Nederlandse Vereniging voor Chirurgische Oncologie (NVCO)coreStrategic or Co-development PartnerNVCO and NVMO co-organize the biennial interdisciplinary congress 'Therapie op Maat' and collaborate on multidisciplinary oncology education. This partnership brings together surgical oncologists, medical oncologists, and radiation oncologists to discuss cross-disciplinary treatment approaches.
• Nederlandse Vereniging voor Radiotherapie en Oncologie (NVRO)coreStrategic or Co-development PartnerNVRO and NVMO co-organize the biennial interdisciplinary congress 'Therapie op Maat' and collaborate on multidisciplinary oncology education alongside NVCO. This partnership addresses the intersection of radiotherapy and medical oncology in cancer treatment.
• BPM MedicaminorOthersBPM Medica provides the editorial execution for the NVMO website and journal Medische Oncologie. The editorial responsibility lies with the NVMO web editorial board, while BPM Medica handles day-to-day editorial production.
• Nederlandse Internisten Vereeniging (NIV)minorStrategic or Co-development PartnerNVMO historically was established because the NIV was insufficient as a forum for oncologically active internists. NIV continues to provide accreditation for NVMO e-learning programs.
• Domus MedicaminorOthersNVMO headquarters is located at Domus Medica, the shared office building of Dutch medical specialist societies in Utrecht.

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

Regional players

• Belgian Society of Medical Oncology (BSMO): BSMO is the Belgian counterpart professional society for medical oncologists, serving the same specialty in a neighboring market. NVMO's Oncologiedagen congress is explicitly held for 'Netherlands and Flanders', indicating direct overlap with BSMO's member base.
• Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie (DGHO): DGHO is the German professional society for hematology and medical oncology, combining two specialties that NVMO treats separately. It operates the same membership-journal-congress model in Germany's larger healthcare market.

Others

• Zorgverzekeraars Nederland (ZN): ZN is the Dutch association of health insurers with which NVMO holds a formal liaison role for add-on oncology drug declaration codes. It is a payer-side counterpart and policy ally rather than a competitive peer.
• MEDtalks: MEDtalks is the Dutch e-learning platform that hosts NVMO's accredited oncology programs under a cooperation agreement. It is a strategic distribution partner and infrastructure provider rather than a competing society.

Direct peers

• European Society for Medical Oncology (ESMO): ESMO is the pan-European professional society for medical oncologists, operating journals, congresses (ESMO Congress), and clinical guidelines that parallel NVMO's scope at the European level. NVMO members actively engage with ESMO's Post-ESMO symposia, indicating direct overlap in membership services and content.
• Nederlandse Vereniging voor Radiotherapie en Oncologie (NVRO): NVRO is the Dutch society for radiation oncologists and completes the multidisciplinary triumvirate (NVMO, NVCO, NVRO) that co-organizes 'Therapie op Maat'. It operates the same membership-and-content model as NVMO but for the radiation oncology specialty.
• Nederlandse Vereniging voor Chirurgische Oncologie (NVCO): NVCO is the Dutch sister society for surgical oncologists and co-organizes the biennial 'Therapie op Maat' congress with NVMO. It mirrors NVMO's structure (national society, journal, committee-driven guidance) within the same Dutch healthcare ecosystem and patient population.
• American Society of Clinical Oncology (ASCO): ASCO is the largest global professional society for oncologists, providing journals (JCO), guidelines, and the annual ASCO Congress. NVMO runs Post-ASCO symposia, directly mirroring ASCO's role in the Netherlands and serving the same medical oncology specialty.

Emerging players

• Society for Translational Oncology (STO): STO is a Dutch translational oncology organization that intersects with NVMO's research and educational remit, focusing on bridging lab and clinical practice. It represents an emerging, niche player that complements NVMO's clinical orientation.

Broad incumbents

• Nederlandse Internisten Vereeniging (NIV): NIV is the broader Dutch internists society that NVMO originally spun out of in 1997, and which still accredits NVMO's e-learning programs. It is the over-arching internal-medicine specialty society serving a wider clinical audience than NVMO's oncology focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/nvmo

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nederlandse Vereniging voor Medische Oncologie